MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays-Reference-Cited by-同舟云学术

MALDI mass spectrometric imaging based identification of clinically relevant signals in prostate cancer using large-scale tissue microarrays

Published:2013-03-04 Issue:4 Volume:133 Page:920-928
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Steurer Stefan¹,Borkowski Carina¹,Odinga Sinje¹,Buchholz Malte¹,Koop Christina¹,Huland Hartwig²,Becker Michael³,Witt Matthias³,Trede Dennis⁴,Omidi Maryam⁵,Kraus Olga⁵,Bahar Ahmad S.¹,Seddiqi A. Shoaib¹,Singer Julius M.¹,Kwiatkowski Marcel⁵,Trusch Maria⁶,Simon Ronald¹,Wurlitzer Marcus⁵,Minner Sarah¹,Schlomm Thorsten²,Sauter Guido¹,Schlüter Hartmut⁵

Affiliation:

1. Institute of Pathology; University Medical Center Hamburg-Eppendorf; Germany

2. Martini-Clinic at University Medical Center Hamburg-Eppendorf; Germany

3. Bruker Daltonik GmbH; Bremen; Germany

4. Steinbeis Innovation Center SCiLS (Scientific Computing in Life Sciences); Bremen; Germany

5. Institute of Clinical Chemistry; Mass Spectrometric Proteomics; University Medical Center Hamburg-Eppendorf; Germany

6. Institute of Organic Chemistry; Mass Spectrometry; University of Hamburg; Germany

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference46 articles.